|
Clinical observation of Canelim
Capsules combined with chemotherapy on 86 cases terminal
stage primary lung cancer
Zhou H. Ben , et al. HeNan Oncology
Hospital
Result:
|
Croup
|
Cases
|
CR
|
PR
|
SD
|
PD
|
Total Effective % (CR+PR)
|
|
Canelim
|
86
|
9
|
42
|
28
|
7
|
59.3
|
|
Control
|
82
|
4
|
27
|
38
|
13
|
37.8
|
Treatment methods:
Control Group: chemotherapy CE (CBP+Vp-16) or CAV (CTX+ADM+VCR)
for small cell lung cancer
 chemotherapy
CAD (CTX+ADM+DDP) or AED(ADM+VP-16+DDP) for non-small
cell lung cancer
Canelim Group: Canelim Capsules, 6 *3 times/day, 8 weeks,
combined with above chemotherapy treatment
Discuss:
In the Canelim group,
9 cases get complete remision, 51 (59.3%) total effective,
compared with 4, 31(37.8%) respectively in the Control
group, the difference is significant (P<0.01).
Conclusion:
Canelim Capsules has apparent anti-cancer effect on
primary lung cancer and can greatly enhance the healing
effect when combined with chemotherapy.
|
Papers
& Reports
